Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity

Frontiers in Behavioral Neuroscience

Volumn 8, Issue JAN, 2015, Pages

  Shelton, Jonathan ^a   Yun, Sujin ^a   Olson, Susan Losee ^b   Turek, Fred ^b   Bonaventure, Pascal ^a   Dvorak, Curt ^a   Lovenberg, Timothy ^a   Dugovic, Christine ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

5 HT7 receptor; Circadian rhythms; Depression; Mood; Non photic; Phase shift; Photic; Serotonin

Indexed keywords

1 BENZYL 3 (4 CHLOROPHENYL) 1,4,5,6,7,8 HEXAHYDROPYRAZOLO[3,4 D]AZEPINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; LIGHT EXPOSURE; MOUSE; NONHUMAN; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; RUNNING; SEROTONINERGIC SYSTEM;

EID: 84921282185     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00453     Document Type: Article

References (71)

1. Adriani, W., Travaglini, D., Lacivita, E., Saso, L., Leopoldo, M., and Laviola, G. (2012). Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. Neuropharmacology 62, 833-842. doi: 10.1016/j.neuropharm.2011.09.012
2. Antle, M. C., Marchant, E. G., Niel, L., and Mistlberger, R. E. (1998). Serotonin antagonists do not attenuate activity-induced phase shifts of circadian rhythms in the Syrian hamster. Brain Res. 813, 139-149. doi: 10.1016/s0006-8993(98)01048-8
3. Belenky, M. A., and Pickard, G. E. (2001). Subcellular distribution of 5-HT(1B) and 5-HT(7) receptors in the mouse suprachiasmatic nucleus. J. Comp. Neurol. 432, 371-388. doi: 10.1002/cne.1109
4. Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., and Smeraldi, E. (2003). Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J. Clin. Psychiatry 64, 648-653. doi: 10.4088/jcp.v64n0605
5. Blier, P. (2003). The pharmacology of putative early-onset antidepressant strategies. Eur. Neuropsychopharmacol. 13, 57-66. doi: 10.1016/s0924-977x(02)00173-6
6. Bloch, G., Herzog, E. D., Levine, J. D., and Schwartz, W. J. (2013). Socially synchronized circadian oscillators. Proc. Biol. Sci. 280:20130035. doi: 10.1098/rspb.2013.0035
7. Bonaventure, P., Dugovic, C., Kramer, M., De Boer, P., Singh, J., Wilson, S., et al. (2012). Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder. J. Pharmacol. Exp. Ther. 342, 429-440. doi: 10.1124/jpet.112.193995
8. Bonaventure, P., Kelly, L., Aluisio, L., Shelton, J., Lord, B., Galici, R., et al. (2007). Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 321, 690-698. doi: 10.1124/jpet.107.119404
9. Bonaventure, P., Nepomuceno, D., Kwok, A., Chai, W., Langlois, X., Hen, R., et al. (2002). Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. J. Pharmacol. Exp. Ther. 302, 240-248. doi: 10.1124/jpet.302.1.240
10. Ciarleglio, C. M., Resuehr, H. E., and McMahon, D. G. (2011). Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues. Neuroscience 197, 8-16. doi: 10.1016/j.neuroscience.2011.09.036
11. Cuesta, M., Clesse, D., Pévet, P., and Challet, E. (2009). New light on the serotonergic paradox in the rat circadian system. J. Neurochem. 110, 231-243. doi: 10.1111/j.1471-4159.2009.06128.x
12. Cuesta, M., Mendoza, J., Clesse, D., Pevet, P., and Challet, E. (2008). Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp. Neurol. 210, 501-513. doi: 10.1016/j.expneurol.2007.11.026
13. Daan, S., and Pittendrigh, C. S. (1976). A functional analysis of circadian pacemakers in nocturnal rodents. J. Comp. Physiol. 106, 253-266. doi: 10.1007/bf01417857
14. Duncan, M. J., and Congleton, M. R. (2010). Neural mechanisms mediating circadian phase resetting by activation of 5-HT(7) receptors in the dorsal raphe: Roles of GABAergic and glutamatergic neurotransmission. Brain Res. 1366, 110-119. doi: 10.1016/j.brainres.2010.09.103
15. Duncan, M. J., and Davis, V. A. (2005). Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Res. 1058, 10-16. doi: 10.1016/j.brainres.2005.07.016
16. Duncan, M. J., Grear, K. E., and Hoskins, M. A. (2004). Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Res. 1008, 40-48. doi: 10.1016/j.brainres.2004.02.025
17. Ehlen, J. C., Grossman, G. H., and Glass, J. D. (2001). In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus. J. Neurosci. 21, 5351-5357.
18. Faradji, H., Cespuglio, R., and Jouvet, M. (1983). Voltammetric measurements of 5-hydroxyindole compounds in the suprachiasmatic nuclei: circadian fluctuations. Brain Res. 279, 111-119. doi: 10.1016/0006-8993(83)90168-3
19. Gamble, K. L., Paul, K. N., Karom, M. C., Tosini, G., and Albers, H. E. (2006). Paradoxical effects of NPY in the suprachiasmatic nucleus. Eur. J. Neurosci. 23, 2488-2494. doi: 10.1111/j.1460-9568.2006.04784.x
20. Gannon, R. L., and Millan, M. J. (2007). Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms. Psychopharmacology (Berl) 195, 325-332. doi: 10.1007/s00213-007-0903-z
21. Gardani, M., and Biello, S. M. (2008). The effects of photic and nonphotic stimuli in the 5-HT7 receptor knockout mouse. Neuroscience 152, 245-253. doi: 10.1016/j.neuroscience.2007.10.028
22. Glass, J. D., Grossman, G. H., Farnbauch, L., and Dinardo, L. (2003). Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J. Neurosci. 23, 7451-7460.
23. Gooley, J. J., Lu, J., Chou, T. C., Scammell, T. E., and Saper, C. B. (2001). Melanopsin in cells of origin of the retinohypothalamic tract. Nat. Neurosci. 4:1165. doi: 10.1038/nn768
24. Grandin, L. D., Alloy, L. B., and Abramson, L. Y. (2006). The social zeitgeber theory, circadian rhythms and mood disorders: review and evaluation. Clin. Psychol. Rev. 26, 679-694. doi: 10.1016/j.cpr.2006.07.001
25. Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., et al. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48, 492-502. doi: 10.1016/j.neuropharm.2004.11.015
26. Hagan, J. J., Price, G. W., Jeffrey, P., Deeks, N. J., Stean, T., Piper, D., et al. (2000). Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br. J. Pharmacol. 130, 539-548. doi: 10.1038/sj.bjp.0703357
27. Harsing, L. G. Jr., Prauda, I., Barkoczy, J., Matyus, P., and Juranyi, Z. (2004). A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem. Res. 29, 1487-1497. doi: 10.1023/b:nere.0000029560.14262.39
28. Hattar, S., Liao, H. W., Takao, M., Berson, D. M., and Yau, K. W. (2002). Melanopsin-containing retinal ganglion cells: architecture, projections and intrinsic photosensitivity. Science 295, 1065-1070. doi: 10.1126/science.1069609
29. Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., and Sutcliffe, J. G. (2005). 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol. Psychiatry 58, 831-837. doi: 10.1016/j.biopsych.2005.05.012
30. Horikawa, K., Fuji, K., Fukazawa, Y., and Shibata, S. (2013). Two distinct serotonin receptors co-mediate non-photic signals to the circadian clock. J. Pharmacol. Sci. 123, 402-406. doi: 10.1254/jphs.13170sc
31. Horikawa, K., and Shibata, S. (2004). Phase-resetting response to (+)8-OH-DPAT, a serotonin 1A/7 receptor agonist, in the mouse in vivo. Neurosci. Lett. 368, 130-134. doi: 10.1016/j.neulet.2004.06.072
32. Hughes, A. T., and Piggins, H. D. (2012). Feedback actions of locomotor activity to the circadian clock. Prog. Brain Res. 199, 305-336. doi: 10.1016/b978-0-444-59427-3.00018-6
33. Klein, D. C., Moore, R. Y., and Reppert, S. M. (1991). Suprachiasmatic Nucleus. The Mind’s Clock. New York: Oxford University Press.
34. Lall, G. S., Atkinson, L. A., Corlett, S. A., Broadbridge, P. J., and Bonsall, D. R. (2012). Circadian entrainment and its role in depression: a mechanistic review. J. Neural Transm. 119, 1085-1096. doi: 10.1007/s00702-012-0858-z
35. Lovenberg, T. W., Baron, B. M., De Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., et al. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11, 449-458. doi: 10.1016/0896-6273(93)90149-l
36. Martiny, K. (2004). Adjunctive bright light in non-seasonal major depression. Acta Psychiatr. Scand. Suppl. 110, 7-28. doi: 10.1111/j.1600-0447.2004.00460_2.x
37. Martiny, K., Lunde, M., Simonsen, C., Clemmensen, L., Poulsen, D. L., Solstad, K., et al. (2004). Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatr. Scand. 109, 230-234. doi: 10.1046/j.1600-0447.2003.00256.x
38. Martiny, K., Lunde, M., Undén, M., Dam, H., and Bech, P. (2005a). Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatr. Scand. 112, 117-125. doi: 10.1111/j.1600-0447.2005.00574.x
39. Martiny, K., Lunde, M., Undén, M., Dam, H., and Bech, P. (2005b). Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales. Acta Psychiatr. Scand. 111, 453-459. doi: 10.1111/j.1600-0447.2005.00532.x
40. Matthys, A., Haegeman, G., Van Craenenbroeck, K., and Vanhoenacker, P. (2011). Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol. Neurobiol. 43, 228-253. doi: 10.1007/s12035-011-8175-3
41. Mintz, E. M., Gillespie, C. F., Marvel, C. L., Huhman, K. L., and Albers, H. E. (1997). Serotonergic regulation of circadian rhythms in Syrian hamsters. Neuroscience 79, 563-569. doi: 10.1016/s0306-4522(96)00696-3
42. Moga, M. M., and Moore, R. Y. (1997). Organization of neural inputs to the suprachiasmatic nucleus in the rat. J. Comp. Neurol. 389, 508-534. doi: 10.1002/(sici)1096-9861(19971222)389:3<508::aid-cne11>3.0.co;2-h
43. Monti, J. M., and Jantos, H. (2014). The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness. Rev. Neurosci. 25, 429-437. doi: 10.1515/revneuro-2014-0016
44. Monti, J. M., Leopoldo, M., and Jantos, H. (2008). The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav. Brain Res. 191, 184-189. doi: 10.1016/j.bbr.2008.03.025
45. Monti, J. M., Leopoldo, M., and Jantos, H. (2014). Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat. Behav. Brain Res. 259, 321-329. doi: 10.1016/j.bbr.2013.11.030
46. Moore, R. Y., and Lenn, N. J. (1972). A retinohypothalamic projection in the rat. J. Comp. Neurol. 146, 1-14. doi: 10.1002/cne.901460102
47. Mrosovsky, N. (1996). Locomotor activity and non-photic influences on circadian clocks. Biol. Rev. Camb. Philos. Soc. 71, 343-372. doi: 10.1111/j.1469-185x.1996.tb01278.x
48. Murray, G., and Harvey, A. (2010). Circadian rhythms and sleep in bipolar disorder. Bipolar Disord. 12, 459-472. doi: 10.1111/j.1399-5618.2010.00843.x
49. Neumaier, J. F., Sexton, T. J., Yracheta, J., Diaz, A. M., and Brownfield, M. (2001). Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization and agonist stimulated cFos expression. J. Chem. Neuroanat. 21, 63-73. doi: 10.1016/s0891-0618(00)00092-2
50. Pail, G., Huf, W., Pjrek, E., Winkler, D., Willeit, M., Praschak-Rieder, N., et al. (2011). Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 64, 152-162. doi: 10.1159/000328950
51. Panda, S., Sato, T. K., Castrucci, A. M., Rollag, M. D., Degrip, W. J., Hogenesch, J. B., et al. (2002). Melanopsin (Opn4) requirement for normal lightinduced circadian phase shifting. Science 298, 2213-2216. doi: 10.1126/science.1076848
52. Patton, D. F., and Mistlberger, R. E. (2013). Circadian adaptations to meal timing: neuroendocrine mechanisms. Front. Neurosci. 7:185. doi: 10.3389/fnins.2013.00185
53. Pendergast, J. S., and Yamazaki, S. (2014). Effects of light, food and methamphetamine on the circadian activity rhythm in mice. Physiol. Behav. 128, 92-98. doi: 10.1016/j.physbeh.2014.01.021
54. Pickard, G. E., and Rea, M. A. (1997). Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms. Biol. Cell 89, 513-523. doi: 10.1016/s0248-4900(98)80007-5
55. Poncet, L., Denoroy, L., and Jouvet, M. (1993). Daily variations in in vivo tryptophan hydroxylation and in the contents of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of the rat. J. Neural Transm. Gen. Sect. 92, 137-150. doi: 10.1007/bf01244873
56. Rea, M. A. (1998). Photic entrainment of circadian rhythms in rodents. Chronobiol. Int. 15, 395-423. doi: 10.3109/07420529808998699
57. Rea, M. A., Glass, J. D., and Colwell, C. S. (1994). Serotonin modulates photic responses in the hamster suprachiasmatic nuclei. J. Neurosci. 14, 3635-3642.
58. Ruby, N. F., Brennan, T. J., Xie, X., Cao, V., Franken, P., Heller, H. C., et al. (2002). Role of melanopsin in circadian responses to light. Science 298, 2211-2213. doi: 10.1126/science.1076701
59. Salvadore, G., Quiroz, J. A., Machado-Vieira, R., Henter, I. D., Manji, H. K., and Zarate, C. A. Jr. (2010). The neurobiology of the switch process in bipolar disorder: A review. J. Clin. Psychiatry 71, 1488-1501. doi: 10.4088/JCP.09r05259gre
60. Sarkisyan, G., Roberts, A. J., and Hedlund, P. B. (2010). The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Behav. Brain Res. 209, 99-108. doi: 10.1016/j.bbr.2010.01.022
61. Smith, B. N., Sollars, P. J., Dudek, F. E., and Pickard, G. E. (2001). Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. J. Biol. Rhythms 16, 25-38. doi: 10.1177/074873040101600104
62. Sprouse, J. (2004). Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics. Expert Opin. Ther. Targets 8, 25-38. doi: 10.1517/eott.8.1.25.26408
63. Sprouse, J., Reynolds, L., Fujiwara, R., and Siuciak, J. (2003). Circadian Rhythm Phenotype of 5-HT7 Receptor Knockout Mice: Greater Role for 5-HT1A in Mediating Drug-Induced Phase Shifts. Program No. 512.8. Washington, DC: Society for Neuroscience.
64. Sprouse, J., Reynolds, L., Li, X., Braselton, J., and Schmidt, A. (2004). 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology 46, 52-62. doi: 10.1016/j.neuropharm.2003.08.007
65. Takahashi, J. S., DeCoursey, P. J., Bauman, L., and Menaker, M. (1984). Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature 308, 186-188. doi: 10.1038/308186a0
66. Weber, E. T., Gannon, R. L., and Rea, M. A. (1998). Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster. J. Biol. Rhythms 13, 209-218. doi: 10.1177/074873098129000057
67. Wesołowska, A., Nikiforuk, A., Stachowicz, K., and Tatarczy nska, E. (2006). Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51, 578-586. doi: 10.1016/j.neuropharm.2006.04.017
68. Wesołowska, A., Tatarczy nska, E., Nikiforuk, A., and Chojnacka-Wójcik, E. (2007). Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. Eur. J. Pharmacol. 555, 43-47. doi: 10.1016/j.ejphar.2006.10.001
69. Westrich, L., Sprouse, J., and Sánchez, C. (2013). The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents. Physiol. Behav. 110-111, 42-50. doi: 10.1016/j.physbeh.2012.12.009
70. Wirz-Justice, A., Benedetti, F., Berger, M., Lam, R. W., Martiny, K., Terman, M., et al. (2005). Chronotherapeutics (light and wake therapy) in affective disorders. Psychol. Med. 35, 939-944. doi: 10.1017/s003329170500437x
71. Ying, S. W., and Rusak, B. (1997). 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Res. 755, 246-254. doi: 10.1016/s0006-8993(97)00102-9